David M. Cordas dos Santos

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

David M. Cordas dos Santos

Sep 22, 2024, 04:52 | Blog

Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?

Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…

Sep 11, 2024, 09:23 | Insight

Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…

Jul 24, 2024, 08:12 | Insight

Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma

Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…

Jul 14, 2024, 01:25 | Insight

Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!

Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…

Jul 12, 2024, 19:08 | Insight

Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy

Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…

All: 5 Posts: 1 - 100

'

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

Karen Knudsen: Clinical trials are the most advanced form of cancer care

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023